Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations

References

• Abel, T., & Zukin, R. S. (2008). Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Current Opinion in Pharmacology, 8, 57–64.10.1016/j.coph.2007.12.002
   PubMed Web of Science ®Google Scholar
• Aldana-Masangkay, G. I., & Sakamoto, K. M. (2011). The role of HDAC6 in cancer. Journal of Biomedicine and Biotechnology, 2011, 875–824. doi: 10.1155/2011/875824.
   Google Scholar
• Amadei, A., Linssen, A. B., & Berendsen, H. J. (1993). Essential dynamics of proteins. Proteins: Structure, Function, and Genetics, 17, 412–425.10.1002/(ISSN)1097-0134
   PubMed Web of Science ®Google Scholar
• Bello, M., Gutiérrez, G., & García-Hernández, E. (2012). Structure and dynamics of β-lactoglobulin in complex with dodecyl sulfate and laurate: A molecular dynamics study. Biophysical Chemistry, 165–166, 79–86.10.1016/j.bpc.2012.03.009
   PubMed Web of Science ®Google Scholar
• Bello, M., Valderrama, B., Serrano-Posada, H., & Rudiño-Piñera, E. (2012). Molecular dynamics of a thermostable multicopper oxidase from thermus thermophilus HB27: Structural differences between the apo and holo forms. PLoS One, 7, e40700.10.1371/journal.pone.0040700
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., Van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81, 3684–3690.10.1063/1.448118
   Web of Science ®Google Scholar
• Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91, 43–56.10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Bergman, J. A., Woan, K., Perez-Villarroel, P., Villagra, A., Sotomayor, E. M., & Kozikowski, A. P. (2012). Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth. Journal of Medicinal Chemistry, 55, 9891–9899.10.1021/jm301098e
   PubMed Web of Science ®Google Scholar
• Bertrand, P. (2010). Inside HDAC with HDAC inhibitors. European Journal of Medicinal Chemistry, 45, 2095–2116.10.1016/j.ejmech.2010.02.030
   PubMed Web of Science ®Google Scholar
• Bolden, J. E., Shi, W., Jankowski, K., Kan, C. Y., Cluse, L., Martin, B. P., … Johnstone, R. W. (2013). HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses. Cell Death and Disease, 4, e519.10.1038/cddis.2013.9
   PubMed Web of Science ®Google Scholar
• Butler, K. V., Kalin, J., Brochier, C., Vistoli, G., Langley, B., & Kozikowski, A. P. (2010). Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. Journal of the American Chemical Society, 132, 10842–10846.10.1021/ja102758v
   PubMed Web of Science ®Google Scholar
• Carew, J. S., Giles, F. J., & Nawrocki, S. T. (2008). Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy. Cancer Letters, 269, 7–17.10.1016/j.canlet.2008.03.037
   PubMed Web of Science ®Google Scholar
• Carey, N., & La Thangue, N. B. (2006). Histone deacetylase inhibitors: Gathering pace. Current Opinion in Pharmacology, 6, 369–375.10.1016/j.coph.2006.03.010
   PubMed Web of Science ®Google Scholar
• Case, D. A., Cheatham 3rd., T. E., Darden, T., Gohlke, H., Luo, R., Merz Jr., K. M., … Woods, R. J. (2005). The Amber biomolecular simulation programs. Journal of Computational Chemistry, 26, 1668–1688.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• Charrier, C., Clarhaut, J., Gesson, J. P., Estiu, G., Wiest, O., Roche, J., & Bertrand, P. (2009). Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression. Journal of Medicinal Chemistry, 52, 3112–3115.10.1021/jm9002439
   PubMed Web of Science ®Google Scholar
• Chen, K., Xu, L., & Wiest, O. (2013). Computational exploration of zinc binding groups for HDAC inhibition. The Journal of Organic Chemistry, 78, 5051–5055.10.1021/jo400406g
   PubMed Web of Science ®Google Scholar
• D’Mello, S. R. (2009). Histone deacetylases as targets for the treatment of human neurodegenerative diseases. Drug News & Perspectives, 22, 513–524.10.1358/dnp.2009.22.9.1437959
   PubMedGoogle Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98, 10089–10092.10.1063/1.464397
   Web of Science ®Google Scholar
• DeLano, W. L. (2002). The PyMOL molecular graphics system. Palo Alto, CA: DeLano Scientific.
   Google Scholar
• Diedrich, D., Hamacher, A., Gertzen, C. G., Alves Avelar, L. A., Reiss, G. J., Kurz, T., … Hansen, F. K. (2016). Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors. Chemical Communications, 52, 3219–3222.10.1039/C5CC10301K
   PubMed Web of Science ®Google Scholar
• Ding, N., Ping, L., Feng, L., Zheng, X., Song, Y., & Zhu, J. (2014). Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells. Cancer Cell International, 14, 139.
   PubMed Web of Science ®Google Scholar
• Estiu, G., Greenberg, E., Harrison, C. B., Kwiatkowski, N. P., Mazitschek, R., Bradner, J. E., & Wiest, O. (2008). Structural origin of selectivity in class II-selective histone deacetylase inhibitors. Journal of Medicinal Chemistry, 51, 2898–2906.10.1021/jm7015254
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., … Pople, J. A. (2004). Gaussian 03. Wallingford, CT: Gaussian.
   Google Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10, 449–461.10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Gohlke, H., & Case, D. A. (2004). Converging free energy estimates: MM-PB(GB)SA studies on the protein–protein complex Ras–Raf. Journal of Computational Chemistry, 25, 238–250.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• Götz, A. W., Williamson, M. J., Xu, D., Poole, D., Le Grand, S., & Walker, R. C. (2012). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. Journal of Chemical Theory and Computation, 8, 1542–1555.10.1021/ct200909j
   PubMed Web of Science ®Google Scholar
• Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999). Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proceedings of the National Academy of Sciences, 96, 4868–4873.10.1073/pnas.96.9.4868
   PubMed Web of Science ®Google Scholar
• Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003). Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proceedings of the National Academy of Sciences, 100, 4389–4394.10.1073/pnas.0430973100
   PubMed Web of Science ®Google Scholar
• Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics, 65, 712–725.10.1002/prot.v65:3
   PubMed Web of Science ®Google Scholar
• Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., … Yao, T. P. (2002). HDAC6 is a microtubule-associated deacetylase. Nature, 417, 455–458.10.1038/417455a
   PubMed Web of Science ®Google Scholar
• Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012). ZINC: A free tool to discover chemistry for biology. Journal of Chemical Information and Modeling, 52, 1757–1768.10.1021/ci3001277
   PubMed Web of Science ®Google Scholar
• Jiang, W., & Roux, B. (2010). Free energy perturbation hamiltonian replica-exchange molecular dynamics (FEP/H-REMD) for absolute ligand binding free energy calculations. Journal of Chemical Theory and Computation, 6, 2559–2565.10.1021/ct1001768
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79, 926.10.1063/1.445869
   Web of Science ®Google Scholar
• Kabsch, W., & Sander, C. (1983). Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 22, 2577–2637.10.1002/(ISSN)1097-0282
   PubMed Web of Science ®Google Scholar
• Kaluza, D., Kroll, J., Gesierich, S., Yao, T. P., Boon, R. A., Hergenreider, E., … Urbich, C. (2011). Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin. The EMBO Journal, 30, 4142–4156.10.1038/emboj.2011.298
   PubMed Web of Science ®Google Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., … Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules:  Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33, 889–897.10.1021/ar000033j
   PubMed Web of Science ®Google Scholar
• Kovacs, J. J., Murphy, P. J., Gaillard, S., Zhao, X., Wu, J. T., Nicchitta, C. V., … Yao, T. P. (2005). HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Molecular Cell, 18, 601–607.10.1016/j.molcel.2005.04.021
   PubMed Web of Science ®Google Scholar
• Kozikowski, A. P., Tapadar, S., Luchini, D. N., Kim, K. H., & Billadeau, D. D. (2008). Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: A new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. Journal of Medicinal Chemistry, 51, 4370–4373.10.1021/jm8002894
   PubMed Web of Science ®Google Scholar
• Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996). AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. Journal of Biomolecular NMR, 8, 477–486.
   PubMed Web of Science ®Google Scholar
• Li, Y., Shin, D., & Kwon, S. H. (2013). Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes. The FEBS Journal, 280, 775–793.
   PubMed Web of Science ®Google Scholar
• Lindahl, E., Hess, B., & van der Spoel, D. (2001). GROMACS 3.0: A package for molecular simulation and trajectory analysis. Journal of Molecular Modeling, 7, 306–317.
   Web of Science ®Google Scholar
• Lindorff-Larsen, K., Maragakis, P., Piana, S., Eastwood, M. P., Dror, R. O., & Shaw, D. E. (2012). Systematic validation of protein force fields against experimental data. PLoS One, 7, e32131.10.1371/journal.pone.0032131
   PubMed Web of Science ®Google Scholar
• Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins, 78, 1950–1958.
   PubMed Web of Science ®Google Scholar
• Liu, J., Liu, M., Yao, Y., Wang, J., Li, Y., Li, G., & Wang, Y. (2012). Identification of novel potential β-N-acetyl-D-hexosaminidase inhibitors by virtual screening, molecular dynamics simulation and MM-PBSA calculations. International Journal of Molecular Sciences, 13, 4545–4563.10.3390/ijms13044545
   PubMed Web of Science ®Google Scholar
• Marchler-Bauer, A., Anderson, J. B., Cherukuri, P. F., DeWeese-Scott, C., Geer, L. Y., Gwadz, M., … Bryant, S. H. (2005). CDD: A conserved domain database for protein classification. Nucleic Acids Res, 33, D192–196.
   PubMed Web of Science ®Google Scholar
• Marcus, A. I., Zhou, J., O’Brate, A., Hamel, E., Wong, J., Nivens, M., … Giannakakou, P. (2005). The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase. Cancer Research, 65, 3883–3893.10.1158/0008-5472.CAN-04-3757
   PubMed Web of Science ®Google Scholar
• Marks, P. (2003). Histone deacetylases. Current Opinion in Pharmacology, 3, 344–351.10.1016/S1471-4892(03)00084-5
   PubMed Web of Science ®Google Scholar
• Marks, P. A., & Dokmanovic, M. (2005). Histone deacetylase inhibitors: Discovery and development as anticancer agents. Expert Opinion on Investigational Drugs, 14, 1497–1511.10.1517/13543784.14.12.1497
   PubMed Web of Science ®Google Scholar
• Marks, P., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001). Histone deacetylases and cancer: Causes and therapies. Nature Reviews Cancer, 1, 194–202.10.1038/35106079
   PubMed Web of Science ®Google Scholar
• Miller 3rd., B. R., McGee Jr., T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8, 3314–3321.10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19, 1639–1662.10.1002/(ISSN)1096-987X
   Web of Science ®Google Scholar
• Nusinzon, I., & Horvath, C. M. (2006). Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. Molecular and Cellular Biology, 26, 3106–3113.10.1128/MCB.26.8.3106-3113.2006
   PubMed Web of Science ®Google Scholar
• Onufriev, A., Bashford, D., & Case, D. A. (2004). Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins: Structure, Function, and Bioinformatics, 55, 383–394.10.1002/prot.20033
   PubMed Web of Science ®Google Scholar
• Ouyang, H., Ali, Y. O., Ravichandran, M., Dong, A., Qiu, W., MacKenzie, F., … Zhai, R. G. (2012). Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini. Journal of Biological Chemistry, 287, 2317–2327.10.1074/jbc.M111.273730
   PubMed Web of Science ®Google Scholar
• Ozaki, T., Wu, D., Sugimoto, H., Nagase, H., & Nakagawara, A. (2013). Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage. Cell Death and Disease, 4, e610.10.1038/cddis.2013.127
   PubMed Web of Science ®Google Scholar
• Pang, Y.-P. (1999). Novel zinc protein molecular dynamics simulations: Steps toward antiangiogenesis for cancer treatment. Journal of Molecular Modeling, 5, 196–202.10.1007/s008940050119
   Web of Science ®Google Scholar
• Pang, Y. P., Xu, K., Yazal, J. E., Prendergas, F. G. (2000). Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach. Protein Science, 9, 1857–1865.
   PubMed Web of Science ®Google Scholar
• Raucci, R., Colonna, G., Giovane, A., Castello, G., & Costantini, S. (2014). N-terminal region of human chemokine receptor CXCR3: Structural analysis of CXCR3(1-48) by experimental and computational studies. Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics, 1844, 1868–1880.10.1016/j.bbapap.2014.08.004
   PubMed Web of Science ®Google Scholar
• Rizzuti, B., Sportelli, L., & Guzzi, R. (2007). Structural, dynamical and functional aspects of the inner motions in the blue copper protein azurin. Biophysical Chemistry, 125, 532–539.10.1016/j.bpc.2006.11.003
   PubMed Web of Science ®Google Scholar
• Saji, S., Kawakami, M., Hayashi, S., Yoshida, N., Hirose, M., Horiguchi, S., … Toi, M. (2005). Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene, 24, 4531–4539.10.1038/sj.onc.1208646
   PubMed Web of Science ®Google Scholar
• Salomon-Ferrer, R., Götz, A. W., Poole, D., Le Grand, S., & Walker, R. C. (2013). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh ewald. Journal of Chemical Theory and Computation, 9, 3878–3888.10.1021/ct400314y
   PubMed Web of Science ®Google Scholar
• Santo, L., Hideshima, T., Kung, A. L., Tseng, J. C., Tamang, D., Yang, M., … Raje, N. (2012). Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma. Blood, 119, 2579–2589.10.1182/blood-2011-10-387365
   PubMed Web of Science ®Google Scholar
• Santos-Martins, D., Forli, S., Ramos, M. J., & Olson, A. J. (2014). AutoDock4 Zn : An improved autodock force field for small-molecule docking to zinc metalloproteins. Journal of Chemical Information and Modeling, 54, 2371–2379.10.1021/ci500209e
   PubMed Web of Science ®Google Scholar
• Sarkar, R., Mukherjee, A., Mukherjee, S., Biswas, R., Biswas, J., & Roy, M. (2014). Curcumin augments the efficacy of antitumor drugs used in leukemia by modulation of heat shock proteins via HDAC6. Journal of Environmental Pathology, Toxicology and Oncology, 33, 247–263.10.1615/JEnvironPatholToxicolOncol.v33.i3
   PubMed Web of Science ®Google Scholar
• Schäfer, S., Saunders, L., Eliseeva, E., Velena, A., Jung, M., Schwienhorst, A., … Jung, M. (2008). Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). Bioorganic & Medicinal Chemistry, 16, 2011–2033.10.1016/j.bmc.2007.10.092
   PubMed Web of Science ®Google Scholar
• Simões-Pires, C., Zwick, V., Nurisso, A., Schenker, E., Carrupt, P. A., & Cuendet, M. (2013). HDAC6 as a target for neurodegenerative diseases: What makes it different from the other HDACs? Molecular Neurodegeneration, 8, 7.10.1186/1750-1326-8-7
   PubMed Web of Science ®Google Scholar
• Sixto-López, Y., Gómez-Vidal, J. A., & Correa-Basurto, J. (2014). Exploring the potential binding sites of some known HDAC inhibitors on some HDAC8 conformers by docking studies. Applied Biochemistry and Biotechnology, 173, 1907–1926.10.1007/s12010-014-0976-1
   PubMed Web of Science ®Google Scholar
• Su, M., Sun, X., & Liu, C. F. (2010). Histone deacetylase 6: The key regulator of misfolded proteins. Sheng Li Ke Xue Jin Zhan, 41, 112–116.
   PubMedGoogle Scholar
• Tambunan, U. S., Bakri, R., Prasetia, T., Parikesit, A. A., & Kerami, D. (2013). Molecular dynamics simulation of complex histones deacetylase (HDAC) Class II homo sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer. Bioinformation, 9, 696–700.10.6026/bioinformation
   PubMedGoogle Scholar
• Uversky, V. N. (2013). Unusual biophysics of intrinsically disordered proteins. Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics, 1834, 932–951.10.1016/j.bbapap.2012.12.008
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701–1718.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• van Gunsteren, W. F., & Berendsen, H. J. C. (1977). Algorithms for macromolecular dynamics and constraint dynamics. Molecular Physics, 34, 1311–1327.10.1080/00268977700102571
   Web of Science ®Google Scholar
• Vishwakarma, S., Iyer, L. R., Muley, M., Singh, P. K., Shastry, A., Saxena, A., … Narayanan, S. (2013). Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects. International Immunopharmacology, 16, 72–78.10.1016/j.intimp.2013.03.016
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25, 1157–1174.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• Yan, C., Xiu, Z., Li, X., Li, S., Hao, C., & Teng, H. (2008). Comparative molecular dynamics simulations of histone deacetylase-like protein: Binding modes and free energy analysis to hydroxamic acid inhibitors. Proteins: Structure, Function, and Bioinformatics, 73, 134–149.10.1002/prot.22047
   PubMed Web of Science ®Google Scholar
• Yoshida, N., Omoto, Y., Inoue, A., Eguchi, H., Kobayashi, Y., Kurosumi, M., … Hayashi, S.-I. (2004). Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes. Cancer Science, 95, 496–502.10.1111/cas.2004.95.issue-6
   PubMed Web of Science ®Google Scholar
• Zhang, Y. (2008). I-TASSER server for protein 3D structure prediction. BMC Bioinformatics, 9, 40. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1821531610.1186/1471-2105-9-40
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Gilquin, B., Khochbin, S., & Matthias, P. (2006). Two catalytic domains are required for protein deacetylation. The Journal of Biological Chemistry, 281, 2401–2404.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S., & Matthias, P. (2003). HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. The EMBO Journal, 22, 1168–1179.10.1093/emboj/cdg115
   PubMed Web of Science ®Google Scholar
• Zhang, X., Yuan, Z., Zhang, Y., Yong, S., Salas-Burgos, A., Koomen, J., … Seto, E. (2007). HDAC6 modulates cell motility by altering the acetylation level of cortactin. Molecular Cell, 27, 197–213.10.1016/j.molcel.2007.05.033
   PubMed Web of Science ®Google Scholar
• Zou, H., Wu, Y., Navre, M., & Sang, B. C. (2006). Characterization of the two catalytic domains in histone deacetylase 6. Biochemical and Biophysical Research Communications, 341, 45–50.10.1016/j.bbrc.2005.12.144
   PubMed Web of Science ®Google Scholar